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Background: 
 Over the past decade, epigenetic modification has been considered to play 
fundamental roles in cell regulatory processes and human diseases. 
Hydroxymethylcytosine (hmC) is a modified form of cytosine, which is enzymatically 
converted from methylcytosine (mC) by TET 1-3 proteins. While mC is a well-known 
epigenetic mark, little is known about its distribution and function. Although changes in 
methylation with aging have been variably described, very little information is available 
on the relationship between hmC and aging. We found that genomic hmC content was 
inversely correlated with age in T cells in human and mouse. The mechanism of hmC 
alteration with age, however, remains to be elucidated. 
 
Purpose: 
 We conducted this study to clarify mechanisms of the age-dependent decrease of 
the hmC content and responsible TET proteins. 
  
Methods:  
[T cell preparation] Human CD3-positive cells were obtained from peripheral blood of 
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53 healthy volunteers (20-83 years). Mouse CD3-positive cells were prepared form 
spleen of 10 6-10-week-old and 10 1.5-2 year-old C57BL/6 mice.  
[Analysis of hmC and mC] Genomic region containing hmC was enriched by the 
hydroxymethylated DNA immunoprecipitation (hMeDIP) method, and analyzed by real 
time PCR. Genomic region containing mC was enriched by the Methylminer 
Methylated DNA Enrichment Kit, and analyzed by real time PCR. 
[Northern blot] Northern blot analysis was used to detect the new exon and the various 
sizes of TET3 mRNA in different cell types.  
[Analysis of the newly identified age-dependent hmC region] The newly identified age-
dependent hmC region (ADHR) of mouse was amplified by PCR and inserted in the 
pGL3 basic vector (ADHR-pGL3basic). ADHR-pGL3basic was methylated by a CpG 
methyltransferase. 293T cells were co-transfected with methylated-ADHR-pGL3basic 
and mouse TET3-pcDNA4. hmC and mC analysis was performed by hMeDIP kit and 
Methylminer Methylated DNA Enrichment Kit, respectively, followed by real-time PCR. 
 
Results: 
Genomic hmC levels and expression levels of TET family genes. 
We found that the mRNA expression levels of TET1 and TET3 were significantly 
decreased with age in human T cells, while those of TET2 were not changed with age. 
Because the preliminary results indicated that the genomic hmC content was decreased 
with age, we directly compared the genomic hmC content with the mRNA expression 
levels of TET1, TET2, and TET3, and found that the mRNA expression levels of TET3 
were significantly correlated with the hmC content, while those of TET1 and TET2 were 
not.  
We then examined mRNA expression levels of mouse T cells. As we expected, the 
mRNA expression levels of TET1 and TET3 in aged mouse T cells were significantly 
lower than those in young mouse T cells, while those of TET2 were not changed with 
age  
 
Mechanism of age-dependent regulation of TET3 expression. 
 We checked the hmC level in regions which are located on CpG island and on 
the upstream or gene body of mouse TET1 and TET3. We found that a region spanning 
about 300 bp at the upstream of TET3 showed higher hmC levels in young mouse T 
cells than those in aged mouse T cells. This region was located about 13 kb from the 
first coding exon of mouse TET3. In TET1, hmC levels were not different between 
young and aged mouse T cells. 
 In human, we also found a region with 79% homology with that of mouse 
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located approximately 60 kb upstream of the first coding exon of human TET3. The 
hmC levels in this region were decreased with age. In contrast, the mC levels in this 
region were not different between young and aged human T cells. 
 
Discovery of a new exon at the upstream of mouse and human TET3 
 The database of mRNA sequencing indicated that the human ADHR was 
overlapped with the 700 bp transcribed region, which we designated exon 0. By RT-
PCR analysis using primers made from exon 0 to exon 1, the PCR product with the 
expected size, with the 13-kb deduced intron spliced out, was visualized, demonstrating 
that exon 0 was indeed expressed as a part of mRNA. The expression levels of exon 0-
containing mRNA was higher in human T cells prepared from two volunteers at 22 
years old and 29 years old than those prepared from volunteers at 62 years old and 69 
years old, and than several human cell lines (Jurkat, 293T, Hela).  
 We then examined the mRNA species by Northern blot for two mouse cell lines, 
NIH3T3 fibroblast cell line and EL4 lymphoblastic lymphoma cell line, using the probe 
corresponding to a part of the mouse version of exon 0 and exon 3. A single mRNA 
species corresponding to an expected size of 11.6 kb was detected with the exon 0 probe 
in both cell lines, showing a higher expression level in EL4 than in NIH3T3. When the 
exon 3 probe was used, the size of main mRNA species expressed in NIH3T3 appeared 
to be shorter than that expressed in EL4, possibly corresponding to the mRNA species 
with (EL4) and without (NIH3T3) exon 0. 
 
Experimental conversion of mC to hmC in mouse ADHR by TET3  
 In 293T cells co-transfected with the methylated-ADHR-pGL3basic and 
mouseTET3-pcDNA4, we found that the hmC level in ADHR was increased compared 
to the controls, indicating that a part of mC in the ADHR was converted to hmC by 
exogenously expressed mouse TET3. In contrast, the change of mC level in ADHR was 
undetectable, indicating that only a small part of mC was converted to hmC. 
 
 
Discussion: 
 We demonstrated a dramatic age-dependent decrease in the genomic hmC 
content in both human and mouse T cells. This could be caused by the gradual decrease 
in the TET3 expression levels during aging. The decrease in the genomic hmC content 
might play a role in alteration of the T cell function in elderly people.  
 We discovered an age-dependent hmC region (ADHR), in which hmC level was 
naturally decreased in aging process. There are 2 transcription start sites for TET3 gene, 
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one starts from exon 0, the other from exon 1. The usage of these alternative 
transcription start sites may be important. In young T cells, because of the high hmC 
level in ADHR, TET3 transcription may begin with exon 0. This could maintain the 
TET3 mRNA level and facilitate the mC to hmC conversion in ADHR, providing the 
positive feedback system. This auto-regulation might be decreased in aged T cells 
because of the decreased hmC level in ADHR.  
 
Conclusion: 
  
 We demonstrated a potential mechanism of age-dependent epigenetic regulation 
through positive feedback of TET3 expression and mC to hmC conversion in its own 
gene body. This might represent an important physiologic system for alteration of T-cell 
function, as well as susceptibility of T cells to tumorigenesis, after aging. 
